(-)Deprenyl in the treatment of Parkinson's disease.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D001921:Brain / Q000201:enzymology; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008134:Long-Term Care; D008995:Monoamine Oxidase / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000201:enzymology; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000009:adverse effects / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism
D010627:Phenethylamines; D012642:Selegiline; D012701:Serotonin; D007980:Levodopa; D006916:5-Hydroxytryptophan; D008995:Monoamine Oxidase; D004298:Dopamine